Literature DB >> 22681667

Donor-specific CD8+ Foxp3+ T cells protect skin allografts and facilitate induction of conventional CD4+ Foxp3+ regulatory T cells.

N M Lerret1, J L Houlihan, T Kheradmand, K L Pothoven, Z J Zhang, X Luo.   

Abstract

CD4(+) regulatory T cells play a critical role in tolerance induction in transplantation. CD8(+) suppressor T cells have also been shown to control alloimmune responses in preclinical and clinical models. However, the exact nature of the CD8(+) suppressor T cells, their induction and mechanism of function in allogeneic transplantation remain elusive. In this study, we show that functionally suppressive, alloantigen-specific CD8(+) Foxp3(+) T cells can be induced and significantly expanded by stimulating naïve CD8(+) T cells with donor dendritic cells in the presence of IL-2, TGF-β1 and retinoic acid. These CD8(+) Foxp3(+) T cells express enhanced levels of CTLA-4, CCR4 and CD103, inhibit the up-regulation of costimulatory molecules on dendritic cells, and suppress CD4 and CD8 T cell proliferation and cytokine production in a donor-specific and contact-dependent manner. Importantly, upon adoptive transfer, the induced CD8(+) Foxp3(+) T cells protect full MHC-mismatched skin allografts. In vivo, the CD8(+) Foxp3(+) T cells preferentially traffic to the graft draining lymph node where they induce conventional CD4(+) Foxp3(+) T cells and concurrently suppress effector T cell expansion. We conclude that donor-specific CD8(+) Foxp3(+) suppressor T cells can be induced and exploited as an effective form of cell therapy for graft protection in transplantation. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22681667      PMCID: PMC3429694          DOI: 10.1111/j.1600-6143.2012.04120.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  64 in total

1.  Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.

Authors:  Lili Xu; Atsushi Kitani; Ivan Fuss; Warren Strober
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

2.  A novel alloantigen-specific CD8+PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo.

Authors:  Atsushi Izawa; Kazuhiro Yamaura; Monica J Albin; Mollie Jurewicz; Katsunori Tanaka; Michael R Clarkson; Takuya Ueno; Antje Habicht; Gordon J Freeman; Hideo Yagita; Reza Abdi; Todd Pearson; Dale L Greiner; Mohamed H Sayegh; Nader Najafian
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

3.  Chemokines and leukocyte traffic.

Authors:  Federica Sallusto; Marco Baggiolini
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

4.  Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Authors:  Margarita M Velásquez-Lopera; Valerie L Eaton; Nadine M Lerret; Luis A Correa; Robert P Decresce; Luis F García; Andrés Jaramillo
Journal:  Transpl Immunol       Date:  2008-03-20       Impact factor: 1.708

5.  CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells.

Authors:  Muhaimin Rifa'i; Zhe Shi; Shu-Yun Zhang; Young Ho Lee; Hiroshi Shiku; Ken-Ichi Isobe; Haruhiko Suzuki
Journal:  Int Immunol       Date:  2008-05-20       Impact factor: 4.823

6.  Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Nigel D L Savage; Tjitske de Boer; Frédéric Triebel; Annemieke van der Wal; Emile de Heer; Michèl R Klein; Annemieke Geluk; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

7.  Dendritic cell type determines the mechanism of bystander suppression by adaptive T regulatory cells specific for the minor antigen HA-1.

Authors:  Richard A Derks; Ewa Jankowska-Gan; Qingyong Xu; William J Burlingham
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

8.  Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.

Authors:  G Xia; J He; J R Leventhal
Journal:  Am J Transplant       Date:  2008-01-07       Impact factor: 8.086

9.  Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.

Authors:  Amal Ephrem; Souleima Chamat; Catherine Miquel; Sylvain Fisson; Luc Mouthon; Giuseppina Caligiuri; Sandrine Delignat; Sriramulu Elluru; Jagadeesh Bayry; Sebastien Lacroix-Desmazes; José L Cohen; Benoît L Salomon; Michel D Kazatchkine; Srini V Kaveri; Namita Misra
Journal:  Blood       Date:  2007-10-11       Impact factor: 22.113

Review 10.  Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

Authors:  Maria-Grazia Roncarolo; Manuela Battaglia
Journal:  Nat Rev Immunol       Date:  2007-08       Impact factor: 53.106

View more
  28 in total

1.  Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells.

Authors:  Ya Liu; Qin Lan; Ling Lu; Maogen Chen; Zanxian Xia; Jilin Ma; Julie Wang; Huimin Fan; Yi Shen; Bernhard Ryffel; David Brand; Francisco Quismorio; Zhongmin Liu; David A Horwitz; Anping Xu; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2013-07-15       Impact factor: 6.216

2.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Central memory CD8+ T lymphocytes mediate lung allograft acceptance.

Authors:  Alexander Sasha Krupnick; Xue Lin; Wenjun Li; Ryuiji Higashikubo; Bernd H Zinselmeyer; Hollyce Hartzler; Kelsey Toth; Jon H Ritter; Mikhail Y Berezin; Steven T Wang; Mark J Miller; Andrew E Gelman; Daniel Kreisel
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

4.  Working toward immune tolerance in lung transplantation.

Authors:  Xinguo Jiang; Mark R Nicolls
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 5.  High-risk corneal allografts: A therapeutic challenge.

Authors:  Tian Yu; Vijayalakshmi Rajendran; May Griffith; John V Forrester; Lucia Kuffová
Journal:  World J Transplant       Date:  2016-03-24

Review 6.  A naturally occurring CD8(+)CD122(+) T-cell subset as a memory-like Treg family.

Authors:  Shanshan Li; Qingfeng Xie; Yuqun Zeng; Chuan Zou; Xusheng Liu; Shouhai Wu; Haixia Deng; Yang Xu; Xian C Li; Zhenhua Dai
Journal:  Cell Mol Immunol       Date:  2014-05-05       Impact factor: 11.530

7.  Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.

Authors:  Séverine Bézie; Béatrice Charreau; Nadège Vimond; Juliette Lasselin; Nathalie Gérard; Véronique Nerrière-Daguin; Frédérique Bellier-Waast; Franck Duteille; Ignacio Anegon; Carole Guillonneau
Journal:  Blood Adv       Date:  2019-11-26

8.  Antibody-suppressor CD8+ T Cells Require CXCR5.

Authors:  Jason M Zimmerer; Bryce A Ringwald; Steven M Elzein; Christina L Avila; Robert T Warren; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  Transplantation       Date:  2019-09       Impact factor: 4.939

Review 9.  Transplantation tolerance and its outcome during infections and inflammation.

Authors:  Anita S Chong; Maria-Luisa Alegre
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

10.  Osteoclast-induced Foxp3+ CD8 T-cells limit bone loss in mice.

Authors:  Zachary S Buchwald; Jennifer R Kiesel; Chang Yang; Richard DiPaolo; Deborah V Novack; Rajeev Aurora
Journal:  Bone       Date:  2013-06-10       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.